The FTSE 100 index closed up 18.11 points, 0.2%, at 8,102.72. The FTSE 250 ended down 31.60 points, 0.2%, at 20,419.09, and the AIM All-Share closed up 1.84 points, 0.3%, at 712.44.
The Rosebank-based coal miner assumed operational control of Ensham in September after acquring 85% interest in the coal mine located in the Bowen Basin in Queensland. Thungela will now buy the ...
Zephyr said Nabors will drill an extended lateral hole from its existing wellbore at the State 36-2 LNW-CC-R well, at Zephyr's Paradox Basin project in Utah. The rig and crew are expected to mobilise ...
In addition, Haydale has sold its South Korean-based subsidiary, Haydale Technologies (Korea) Co Ltd to its local director, Minon Kim. HTK is currently a distributor of Haydale products serving the ...
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as ...
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as ...
(Alliance News) - Fletcher King PLC on Monday said profit was up in the first half of its current financial year, despite a "challenging" property market. The London-based chartered surveyors firm ...
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as ...
(Alliance News) - The following stocks are the leading risers and fallers on AIM on Monday.
Paul Dales, chief UK economist at Capital Economics, said: "Overall, these data suggest that after a bumper first half of the year, the economy ground to a halt in the second half of the year due to a ...
Goldman Sachs cuts Bunzl price target to 3,175 (3,275) pence - 'sell' UBS cuts Spirax price target to 7,500 (9,300) pence - 'neutral' JPMorgan cuts Schroders price target to 343 (353) pence - 'neutral ...
(Alliance News) - AstraZeneca PLC on Monday said it has received approval in the European Union for Tagrisso, its non-small cell lung cancer treatment.